Throughout the world, patient compliance drops to about 50 percent after three months. Not only is patient adherence a global health risk, but it also costs pharmaceutical manufacturers more than $30 billion a year in lost revenue. According to one study, unit-dose blister packaging, and other innovative packaging, improves refill rate by 15 percent and outcomes by 30 percent.
Source: Outsourcing-pharm.com
